Beurer India Launches GL 22 Blood Glucose Monitor to Enhance Diabetes Care
The GL 22, manufactured under Beurer’s ‘Make in India’ initiative, features advanced monitoring capabilities tailored to the needs of Indian users. It provides average blood glucose readings over 7, 14, 30, and 90 days, offering insights closely aligned with HbA1c levels, which are essential for long-term diabetes management.
Beurer India, a subsidiary of German healthcare leader Beurer GmbH, has introduced the GL 22 Blood Glucose Monitor, aimed at improving diabetes management in the country. The device was unveiled by Sourav Ganguly, cricketer and Beurer’s brand ambassador, during a launch event in Jaipur.
The GL 22, manufactured under Beurer’s ‘Make in India’ initiative, features advanced monitoring capabilities tailored to the needs of Indian users. It provides average blood glucose readings over 7, 14, 30, and 90 days, offering insights closely aligned with HbA1c levels, which are essential for long-term diabetes management.
Sebastian Kebbe, COO and Managing Director of Beurer GmbH, said, “The GL 22 Monitor embodies Beurer’s dedication to delivering high-quality, affordable solutions. By manufacturing under the ‘Make in India’ initiative, we’ve ensured the product is tailored to the needs of Indian consumers, combining world-class quality with affordability.”
Focus on Community Health & Education
At the launch event, Beurer outlined its plans to expand community health outreach. The company intends to work with healthcare professionals and organisations to conduct health camps, train users in diabetes management, and educate people about effective use of health monitoring devices.
The GL 22 Monitor’s design reflects Beurer’s 100-year legacy in health technology. Its focus on accuracy and usability aligns with the company’s broader mission to enhance health outcomes through innovation.
In addition to glucose monitors, Beurer’s portfolio includes devices like blood pressure monitors, nebulisers, and wellness products. The company’s efforts in India are geared towards increasing accessibility to health solutions while maintaining international quality standards.
Ganguly, speaking at the event, said, “As someone who values health, I am proud to be associated with Beurer. This device is a step towards empowering individuals to take charge of their health.”
